Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Observational Study of Patients Receiving DUPIXENT® for Atopic Dermatitis

NCT03428646 is registered in ClinicalTrials.gov with Regeneron Pharmaceuticals as lead sponsor.

NCT NCT03428646
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03428646 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Observational Study of Patients Receiving DUPIXENT® for Atopic Dermatitis
Lead sponsor
Regeneron Pharmaceuticals
Phase
Observational
Overall status
Active, not recruiting
Start date
April 6, 2018
Completion date
July 28, 2027
Enrollment
858 (actual)
Sites
99

Conditions

As the registry lists them; a condition with its own page is linked.

dermatitis, atopic